Spiess PE - Search Results

1

The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies.

Daher R, Ruplin A, Gupta S, Spiess PE, Kamat AM, Cigliola A, Tateo V, Mercinelli C, Grivas P, Necchi A. Daher R, et al. Among authors: spiess pe. Crit Rev Oncol Hematol. 2024 Aug;200:104420. doi: 10.1016/j.critrevonc.2024.104420. Epub 2024 Jun 19. Crit Rev Oncol Hematol. 2024. PMID: 38906514 Review.

2

Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach?

Spiess PE, Kassouf W, Brown G, Highshaw R, Wang X, Do KA, Kamat AM, Czerniak B, Dinney CP, Grossman HB. Spiess PE, et al. Urology. 2006 Mar;67(3):466-71. doi: 10.1016/j.urology.2005.09.043. Urology. 2006. PMID: 16527559

3

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?

Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Spiess PE, et al. Cancer. 2006 Oct 1;107(7):1503-10. doi: 10.1002/cncr.22181. Cancer. 2006. PMID: 16944534 Free article.

4

Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.

Spiess PE, Brown GA, Liu P, Tannir NM, Tu SM, Evans JG, Czerniak B, Kamat AM, Pisters LL. Spiess PE, et al. Cancer. 2006 Oct 1;107(7):1483-90. doi: 10.1002/cncr.22182. Cancer. 2006. PMID: 16944541 Free article.

5

Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience.

Evans JG, Spiess PE, Kamat AM, Wood CG, Hernandez M, Pettaway CA, Dinney CP, Pisters LL. Evans JG, et al. Among authors: spiess pe. J Urol. 2006 Oct;176(4 Pt 1):1463-7. doi: 10.1016/j.juro.2006.06.016. J Urol. 2006. PMID: 16952661

6

Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.

Spiess PE, Brown GA, Liu P, Tu SM, Tannir NM, Evans JG, Kamat AM, Kassouf W, Pisters LL. Spiess PE, et al. J Urol. 2007 Jan;177(1):131-8. doi: 10.1016/j.juro.2006.08.092. J Urol. 2007. PMID: 17162023

7

Review of the M.D. Anderson experience in the treatment of bladder sarcoma.

Spiess PE, Kassouf W, Steinberg JR, Tuziak T, Hernandez M, Tibbs RF, Czerniak B, Kamat AM, Dinney CP, Grossman HB. Spiess PE, et al. Urol Oncol. 2007 Jan-Feb;25(1):38-45. doi: 10.1016/j.urolonc.2006.02.003. Urol Oncol. 2007. PMID: 17208137

8

Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience.

Spiess PE, Kassouf W, Brown GA, Kamat AM, Liu P, Gomez JA, Tu SM, Tannir NM, Pisters LL. Spiess PE, et al. J Urol. 2007 Apr;177(4):1330-4; discussion 1334. doi: 10.1016/j.juro.2006.11.086. J Urol. 2007. PMID: 17382725

9

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.

Kassouf W, Spiess PE, Brown GA, Munsell MF, Grossman HB, Siefker-Radtke A, Dinney CP, Kamat AM. Kassouf W, et al. Among authors: spiess pe. Eur Urol. 2007 Sep;52(3):769-74. doi: 10.1016/j.eururo.2007.03.086. Epub 2007 Apr 10. Eur Urol. 2007. PMID: 17434254 Free PMC article.

10

Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?

Spiess PE, Tannir NM, Tu SM, Brown GA, Liu P, Kamat AM, Wood CG, Evans JG, Pisters LL. Spiess PE, et al. Cancer. 2007 Dec 15;110(12):2700-8. doi: 10.1002/cncr.23104. Cancer. 2007. PMID: 17948916 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters